Multiplex Immunoassay Biochip

Biochip Array Technology is a novel proprietary technology from Randox Biosciences. Biochip Array Technology (BAT) is an exquisite precision in multiplex testing platform allowing the simultaneous quantitative or qualitative detection of a wide range of analytes from a single sample. It provides a unique platform for assessment of biological samples in a rapid, accurate and easy to use format.

Biochip Array Technology and the Evidence analyser are a solution which produces a complete patient profile, providing exceptional time, resource and cost savings.

BAT uniquely offers immunoassay diagnostic testing for simultaneous multi-analyte Biomarker detection. After addition of a single patient sample to the biochip, analytes present in the sample bind to the specific Biochip bound ligands. The degree of binding is determined using a chemiluminescent light source and quantified using a Charge Coupled Device (CCD) camera and imaging system.

Each biochip has 25 Discrete Test Regions (DTR’s) which each detect a different Biomarker. This means that 23 tests can be carried out simultaneously with two additional DTR’s reserved for internal quality control, a unique Biochip Array Technology feature.

Randox Biosciences offer three biochip analysers, the Evidence, Evidence Investigator, Evidence MultiStat and the Evidence Evolution. Each is suited to a different clinical setting to suit your testing need.

Key Features & Benefits
  • Highly accurate testing with a proven high standard of accurate test results with CV’s <10%
  • Testing for multiple markers allows for more informed patient diagnosis
  • Multi-analyte reagents and quality control material, provides highly efficient testing while eliminating any wastage
  • Reduced sample volume requirements puts the patient at ease
  • Patient profiling saves precious sample if further analysis is required
  • Cost consolidation as multiplex testing reduces the amount of time spent on individual tests and associated laboratory costs
  • Wide and varied test menu allows clinicians to detect routine and novel markers for advanced diagnostic analysis
  • Extensive quality control features with internal quality control markers on every biochip ensure optimum assay performance as QC data is automatically created and displayed with every patient result
  • Multiple sample types can be used on one analyser including serum, plasma, whole blood, urine, oral fluid and alternative matrices which allows the clinician to offer flexible patient testing
  • Result traceability as biochips and patient samples are bar coded
  • Retrospective reporting by retrieve previously unreported results without additional testing, saving time
Applications of Biochip Technology
  • Academic Research
  • Drug Development: Pre-clinical and clinical studies (CRO’s and Pharma)
  • Forensic and Clinical Toxicology
  • Veterinary Testing
  • Molecular Research and Diagnostics

Get in touch to discover more